<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6"><labelDrug name="NitroMist"><Normalization><mmtx cui="C1948383" preferredWord="NitroMist" semType="phsu"/></Normalization></labelDrug><generic name="nitroglycerin"/><sentence id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.1" text="NITROMIST (nitroglycerin) aerosol, metered" type="negative"><entity charOffset="0:9" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.1.e.0" text="nitromist" type="Biomedical_Entity"><Normalization><mmtx cui="C1948383" phraseText="NITROMIST" preferredWord="NitroMist" semType="phsu"/><RxNorm RxCui="705130"/></Normalization></entity><entity charOffset="11:24" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.1.e.1" text="nitroglycerin" type="Biomedical_Entity"><Normalization><mmtx cui="C0885378" phraseText="(nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><pair ddi="false" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.1.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.1.e.1"/></sentence><sentence id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.2" text="Nitroglycerin, an organic nitrate, is a vasodilator which has effects on both arteries and veins. " type="negative"><entity charOffset="40:51" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.2.e.0" text="vasodilator" type="Biomedical_Entity"><Normalization><mmtx cui="C3537240" phraseText="a vasodilator" preferredWord="Vasodilator [EPC]" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.2.e.1" text="nitroglycerin" type="Biomedical_Entity"><Normalization><mmtx cui="C0885378" phraseText="Nitroglycerin," preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><pair ddi="false" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.2.e.1" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.2.e.0"/></sentence><sentence biomedicalEntities="7" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6" lineNumber="9" text="Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), as PDE5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates [see DRUG INTERACTIONS (7.1)]." type="regular"><entity charOffset="18:27" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.0" text="NitroMist" type="Drug"><Normalization><mmtx cui="C1948383" phraseText="Administration of NitroMist" preferredWord="NitroMist" semType="phsu"/><RxNorm RxCui="705130"/></Normalization></entity><entity charOffset="75:176" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.1" text="selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)" type="Drug_Class"><Normalization><mmtx cui="C0018330" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)," preferredWord="Guanosine" semType="phsu, nnon"/><mmtx cui="C1318700" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)," preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><mmtx cui="C0018330" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)," preferredWord="Guanosine" semType="phsu, nnon"/><mmtx cui="C2923059" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)," preferredWord="Phosphodiesterase 5 Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="31:46" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.2" text="contraindicated" type="SPAN"/><entity charOffset="31:46" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.3" text="contraindicated" type="Caution_Interaction"/><entity charOffset="181:196" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.5" text="PDE5 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="PDE5 inhibitors such as sildenafil," preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><RxNorm RxCui="230032"/></Normalization></entity><entity charOffset="205:215" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.6" text="sildenafil" type="Drug"><Normalization><mmtx cui="C0529793" phraseText="PDE5 inhibitors such as sildenafil," preferredWord="sildenafil" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="217:227" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.7" text="vardenafil" type="Drug"><Normalization><mmtx cui="C0971579" phraseText="vardenafil," preferredWord="vardenafil" semType="phsu, orch"/><RxNorm RxCui="1309396"/></Normalization></entity><entity charOffset="233:242" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.8" text="tadalafil" type="Drug"><Normalization><mmtx cui="C1176316" phraseText="tadalafil" preferredWord="tadalafil" semType="phsu, orch"/><RxNorm RxCui="358263"/></Normalization></entity><entity charOffset="300:316" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.12" text="organic nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="1427579"/></Normalization></entity><entity charOffset="262:296" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.13" text="potentiate the hypotensive effects" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.6" drugClass="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.5"/><drugClassMembership drug="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.7" drugClass="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.5"/><drugClassMembership drug="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.8" drugClass="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.5"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.3"><relations><relation type="hasSeverity"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.ddi.2"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.13"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.12"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.1" severity="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.2" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.3" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.5" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.12" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.6.e.13" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32" lineNumber="49" text="Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). " type="regular"><entity charOffset="75:176" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.0" text="selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)" type="Drug_Class"><Normalization><mmtx cui="C0018330" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)." preferredWord="Guanosine" semType="phsu, nnon"/><mmtx cui="C1318700" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)." preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><mmtx cui="C0018330" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)." preferredWord="Guanosine" semType="phsu, nnon"/><mmtx cui="C2923059" phraseText="a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5)." preferredWord="Phosphodiesterase 5 Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="18:27" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.1" text="NitroMist" type="Drug"><Normalization><mmtx cui="C1948383" phraseText="Administration of NitroMist" preferredWord="NitroMist" semType="phsu"/><RxNorm RxCui="705130"/></Normalization></entity><entity charOffset="31:46" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.2" text="contraindicated" type="Caution_Interaction"/><entity charOffset="31:46" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.4" text="contraindicated" type="SPAN"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.1"/></relation><relation type="hasSeverity"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.1" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.0" severity="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.4" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.32.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33" lineNumber="49" text="PDE5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates." type="regular"><entity charOffset="24:34" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.0" text="sildenafil" type="Drug"><Normalization><mmtx cui="C0529793" phraseText="PDE5 inhibitors such as sildenafil," preferredWord="sildenafil" semType="phsu, orch"/><RxNorm RxCui="136411"/></Normalization></entity><entity charOffset="36:46" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.1" text="vardenafil" type="Drug"><Normalization><mmtx cui="C0971579" phraseText="vardenafil," preferredWord="vardenafil" semType="phsu, orch"/><RxNorm RxCui="1309396"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.2" text="tadalafil" type="Drug"><Normalization><mmtx cui="C1176316" phraseText="tadalafil" preferredWord="tadalafil" semType="phsu, orch"/><RxNorm RxCui="358263"/></Normalization></entity><entity charOffset="0:15" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.3" text="PDE5 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1318700" phraseText="PDE5 inhibitors such as sildenafil," preferredWord="Phosphodiesterase 5 inhibitor" semType="phsu"/><RxNorm RxCui="230032"/></Normalization></entity><entity charOffset="119:135" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.7" text="organic nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="1427579"/></Normalization></entity><entity charOffset="81:115" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.8" text="potentiate the hypotensive effects" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.0" drugClass="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.3"/><drugClassMembership drug="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.1" drugClass="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.3"/><drugClassMembership drug="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.2" drugClass="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.3"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.7"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.3" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.7" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.33.e.8" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38" lineNumber="55" text="Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects. " type="regular"><entity charOffset="19:41" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.0" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="antihypertensive drugs," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="43:67" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.1" text="beta-adrenergic blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="73:81" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.2" text="nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="202927"/></Normalization></entity><entity charOffset="114:142" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.3" text="additive hypotensive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.2" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.1" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.2" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.38.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39" lineNumber="55" text="Marked orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used concomitantly." type="regular"><entity charOffset="54:78" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.0" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="83:99" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.1" text="organic nitrates" type="Drug_Class"><Normalization><RxNorm RxCui="1427579"/></Normalization></entity><entity charOffset="7:30" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.2" text="orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="Marked orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.39.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40" lineNumber="57" text="Labetolol blunts the reflex tachycardia produced by nitroglycerin without preventing its hypotensive effects. " type="regular"><entity charOffset="0:9" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.0" text="Labetolol" type="Drug"><Normalization><mmtx cui="C0022860" phraseText="Labetolol" preferredWord="Labetalol" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="52:65" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.1" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="produced by nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="produced by nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="10:39" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.2" text="blunts the reflex tachycardia" type="Specific_Interaction"/><entity charOffset="89:108" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.4" text="hypotensive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.2"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.ddi.2"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.4"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.40.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41" lineNumber="57" text="If labetolol is used with nitroglycerin in patients with angina pectoris, additional hypotensive effects may occur." type="regular"><entity charOffset="3:12" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.0" text="labetolol" type="Drug"><Normalization><mmtx cui="C0022860" phraseText="labetolol" preferredWord="Labetalol" semType="phsu, orch"/><RxNorm RxCui="6185"/></Normalization></entity><entity charOffset="26:39" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.1" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="used with nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="used with nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="57:72" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.2" text="angina pectoris" type="SPAN"><Normalization><mmtx cui="C0002962" phraseText="with angina pectoris," preferredWord="Angina Pectoris" semType="sosy"/></Normalization></entity><entity charOffset="74:104" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.3" text="additional hypotensive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.3"><relations><relation type="hasContext"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.2" ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.41.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43" lineNumber="61" text="Coadministration of aspirin and nitroglycerin has been reported to result in increased nitroglycerin maximum concentrations by as much as 67% and AUC by 73% when administered as a single dose. " type="regular"><entity charOffset="20:27" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.0" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="Coadministration of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="87:100" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.1" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="result in increased nitroglycerin maximum concentrations" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="result in increased nitroglycerin maximum concentrations" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="77:86|109:123" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.2" text="increased concentrations" type="Increase_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.2"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.43.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44" lineNumber="61" text="The vasodilatory and hemodynamic effects of nitroglycerin may be enhanced by concomitant administration of aspirin." type="regular"><entity charOffset="107:114" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.0" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="enhanced by concomitant administration of aspirin." preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="44:57" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.1" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="hemodynamic effects of nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="hemodynamic effects of nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="4:16|33:40|65:73" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.2" text="vasodilatory effects enhanced" type="Specific_Interaction"/><entity charOffset="21:40|65:73" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.4" text="hemodynamic effects enhanced" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.2"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.ddi.2"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.4"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.1" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.0" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.44.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46" lineNumber="65" text="Intravenous administration of nitroglycerin decreases the thrombolytic effect of tissue-type plasminogen activator (t-PA). " type="regular"><entity charOffset="30:43" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.0" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Intravenous administration of nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Intravenous administration of nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="81:114" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.1" text="tissue-type plasminogen activator" type="Drug"><Normalization><mmtx cui="C0032143" phraseText="the thrombolytic effect of tissue-type plasminogen activator (t-PA)." preferredWord="Alteplase" semType="phsu, aapp, enzy"/><RxNorm RxCui="8410"/></Normalization></entity><entity charOffset="44:77" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.2" text="decreases the thrombolytic effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.46.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47" lineNumber="65" text="Plasma levels of t-PA are reduced when coadministered with nitroglycerin. " type="regular"><entity charOffset="17:21" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.0" text="t-PA" type="Drug"><Normalization><mmtx cui="C0032144" phraseText="Plasma levels of t-PA" preferredWord="Plasminogen Activator" semType="phsu, aapp, enzy"/><mmtx cui="C0032144" phraseText="Plasma levels of t-PA" preferredWord="Plasminogen Activator" semType="phsu, aapp, enzy"/><RxNorm RxCui="8410"/></Normalization></entity><entity charOffset="59:72" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.1" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="coadministered with nitroglycerin." preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="coadministered with nitroglycerin." preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="0:13|26:33" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.2" text="Plasma levels reduced" type="Decrease_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.47.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48" lineNumber="65" text="Therefore, caution should be observed in patients receiving nitroglycerin during t-PA therapy." type="regular"><entity charOffset="60:73" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.0" text="nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="nitroglycerin during t-PA therapy." preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="nitroglycerin during t-PA therapy." preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="81:85" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.1" text="t-PA" type="Drug"><Normalization><mmtx cui="C0032144" phraseText="nitroglycerin during t-PA therapy." preferredWord="Plasminogen Activator" semType="phsu, aapp, enzy"/><mmtx cui="C0032144" phraseText="nitroglycerin during t-PA therapy." preferredWord="Plasminogen Activator" semType="phsu, aapp, enzy"/><RxNorm RxCui="8410"/></Normalization></entity><entity charOffset="11:18|29:37" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.2" text="caution observed" type="Caution_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.2"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.48.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50" lineNumber="69" text="Intravenous nitroglycerin reduces the anticoagulant effect of heparin. " type="regular"><entity charOffset="0:25" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.0" text="Intravenous nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Intravenous nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Intravenous nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="62:69" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.1" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="the anticoagulant effect of heparin." preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="the anticoagulant effect of heparin." preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="26:58" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.2" text="reduces the anticoagulant effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.2"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.50.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51" lineNumber="69" text="Activated partial thromboplastin times (APTT) should be monitored in patients receiving heparin and intravenous nitroglycerin. " type="regular"><entity charOffset="88:95" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.0" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin" preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="100:125" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.1" text="intravenous nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="intravenous nitroglycerin." preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="intravenous nitroglycerin." preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="56:65" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.2" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.2"><relations><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.51.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54" lineNumber="73" text="Oral administration of nitroglycerin markedly decreases the first-pass metabolism of dihydroergotamine and subsequently increases its oral bioavailability. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="130:133" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.4" text="its" type="Expression"/><antecedentEntity charOffset="85-102" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.1" text="dihydroergotamine" type="Drug"/></anaphoraRelation><entity charOffset="0:4|23:36" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.0" text="Oral nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="Oral administration of nitroglycerin markedly" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="Oral administration of nitroglycerin markedly" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="85:102" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.1" text="dihydroergotamine" type="Drug"><Normalization><mmtx cui="C0012291" phraseText="the first-pass metabolism of dihydroergotamine" preferredWord="Dihydroergotamine" semType="phsu, orch"/><RxNorm RxCui="3418"/></Normalization></entity><entity charOffset="120:129|134:154" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.2" text="increases oral bioavailability" type="Increase_Interaction"/><entity charOffset="46:81" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.6" text="decreases the first-pass metabolism" type="Increase_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.ddi.2"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.4" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.54.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56" lineNumber="73" text="Therefore, patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible." type="regular"><entity charOffset="30:54" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.0" text="sublingual nitroglycerin" type="Drug"><Normalization><mmtx cui="C0017887" phraseText="sublingual nitroglycerin" preferredWord="Nitroglycerin" semType="phsu, orch"/><mmtx cui="C0885378" phraseText="sublingual nitroglycerin" preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="68:78" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.1" text="ergotamine" type="Drug"><Normalization><mmtx cui="C0014710" phraseText="ergotamine" preferredWord="Ergotamine" semType="phsu, orch"/><RxNorm RxCui="4026"/></Normalization></entity><entity charOffset="129:137" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.2" text="ergotism" type="Specific_Interaction"/><drugInteraction id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.ddi.1"><interaction trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.1" trigger="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.56.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66" text="After an initial priming of 10 sprays, each metered spray of NitroMist delivers 33 mg of solution containing 400 mcg of nitroglycerin. " type="negative"><entity charOffset="71:79" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.0" text="delivers" type="Biomedical_Entity"><Normalization><mmtx cui="C0308779" phraseText="delivers" preferredWord="DELIVER (veterinary product)" semType="phsu, orch"/><RxNorm RxCui="693491"/></Normalization></entity><entity charOffset="120:133" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.1" text="nitroglycerin" type="Biomedical_Entity"><Normalization><mmtx cui="C0885378" phraseText="400 mcg of nitroglycerin." preferredWord="Glonoine, nitroglycerine, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="4917"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.2" text="nitromist" type="Biomedical_Entity"><Normalization><mmtx cui="C1948383" phraseText="each metered spray of NitroMist" preferredWord="NitroMist" semType="phsu"/><RxNorm RxCui="705130"/></Normalization></entity><pair ddi="false" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.0" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.1"/><pair ddi="false" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.2" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.0"/><pair ddi="false" e1="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.2" e2="Dailymed.1dfb2a25-abbd-4fe2-9531-8c76a7b2efa6.s.66.e.1"/></sentence><positiveExamples number="19"/><negativeExamples number="6"/></document>